Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 16 | 2021 | 1220 | 1.810 |
Why?
|
| Brain Ischemia | 12 | 2017 | 420 | 1.700 |
Why?
|
| Leukoaraiosis | 5 | 2015 | 45 | 1.660 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2015 | 117 | 1.290 |
Why?
|
| Severity of Illness Index | 4 | 2016 | 1567 | 0.970 |
Why?
|
| Cost of Illness | 3 | 2015 | 169 | 0.920 |
Why?
|
| Intracranial Thrombosis | 1 | 2020 | 28 | 0.640 |
Why?
|
| Carotid Artery Diseases | 1 | 2020 | 61 | 0.630 |
Why?
|
| Intracranial Embolism | 1 | 2020 | 41 | 0.630 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2020 | 91 | 0.600 |
Why?
|
| Cerebrum | 1 | 2015 | 16 | 0.460 |
Why?
|
| Brain | 9 | 2018 | 1618 | 0.450 |
Why?
|
| Brain Infarction | 2 | 2012 | 21 | 0.440 |
Why?
|
| White Matter | 3 | 2019 | 128 | 0.360 |
Why?
|
| Vision Disorders | 1 | 2012 | 69 | 0.350 |
Why?
|
| Aged, 80 and over | 12 | 2020 | 5656 | 0.300 |
Why?
|
| Cerebrovascular Circulation | 3 | 2025 | 184 | 0.300 |
Why?
|
| Middle Aged | 20 | 2025 | 18434 | 0.290 |
Why?
|
| Cerebral Hemorrhage | 2 | 2019 | 100 | 0.270 |
Why?
|
| Aged | 20 | 2025 | 15087 | 0.270 |
Why?
|
| Male | 23 | 2025 | 31285 | 0.260 |
Why?
|
| Cerebral Infarction | 3 | 2016 | 85 | 0.250 |
Why?
|
| Retrospective Studies | 14 | 2025 | 6948 | 0.250 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2025 | 49 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2019 | 2252 | 0.220 |
Why?
|
| Atrial Fibrillation | 3 | 2020 | 884 | 0.220 |
Why?
|
| Female | 22 | 2025 | 34298 | 0.210 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2016 | 165 | 0.210 |
Why?
|
| Embolism | 2 | 2016 | 41 | 0.200 |
Why?
|
| Humans | 26 | 2025 | 65635 | 0.190 |
Why?
|
| Risk Factors | 11 | 2025 | 5466 | 0.190 |
Why?
|
| Echo-Planar Imaging | 1 | 2002 | 34 | 0.180 |
Why?
|
| Atrial Remodeling | 1 | 2020 | 23 | 0.150 |
Why?
|
| Atrial Function, Left | 1 | 2020 | 32 | 0.150 |
Why?
|
| Carotid Stenosis | 3 | 2008 | 100 | 0.150 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2020 | 45 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 143 | 0.150 |
Why?
|
| Heart Atria | 1 | 2020 | 137 | 0.150 |
Why?
|
| Thrombolytic Therapy | 2 | 2021 | 204 | 0.150 |
Why?
|
| Antacids | 1 | 2019 | 14 | 0.150 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2018 | 11 | 0.140 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2017 | 8 | 0.130 |
Why?
|
| Eligibility Determination | 1 | 2016 | 37 | 0.120 |
Why?
|
| Pneumonia | 1 | 2019 | 295 | 0.120 |
Why?
|
| Aging | 1 | 2002 | 775 | 0.120 |
Why?
|
| Adult | 8 | 2019 | 17508 | 0.120 |
Why?
|
| Endarterectomy, Carotid | 2 | 2008 | 79 | 0.110 |
Why?
|
| Atherosclerosis | 1 | 2017 | 162 | 0.110 |
Why?
|
| Risk Assessment | 5 | 2020 | 2113 | 0.110 |
Why?
|
| Migraine Disorders | 1 | 2015 | 46 | 0.110 |
Why?
|
| Time-to-Treatment | 1 | 2016 | 133 | 0.110 |
Why?
|
| Heart Diseases | 1 | 2016 | 223 | 0.100 |
Why?
|
| Patient Selection | 1 | 2016 | 484 | 0.100 |
Why?
|
| United States | 2 | 2015 | 8166 | 0.090 |
Why?
|
| Diffusion | 2 | 2002 | 82 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2018 | 3328 | 0.090 |
Why?
|
| Retina | 1 | 2012 | 135 | 0.090 |
Why?
|
| Endovascular Procedures | 1 | 2016 | 631 | 0.070 |
Why?
|
| Prognosis | 4 | 2020 | 1791 | 0.070 |
Why?
|
| Factor V | 1 | 2009 | 2 | 0.070 |
Why?
|
| Recurrence | 2 | 2025 | 664 | 0.070 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2009 | 67 | 0.070 |
Why?
|
| Heterozygote | 1 | 2009 | 173 | 0.070 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2004 | 186 | 0.060 |
Why?
|
| Time Factors | 4 | 2016 | 3777 | 0.060 |
Why?
|
| Thrombosis | 1 | 2009 | 207 | 0.060 |
Why?
|
| Registries | 3 | 2016 | 933 | 0.060 |
Why?
|
| Perfusion Imaging | 1 | 2025 | 22 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 1116 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 326 | 0.050 |
Why?
|
| Cognition | 1 | 2008 | 511 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2016 | 579 | 0.050 |
Why?
|
| Prevalence | 1 | 2007 | 1453 | 0.050 |
Why?
|
| Intracranial Aneurysm | 1 | 2007 | 382 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2007 | 529 | 0.050 |
Why?
|
| Age Factors | 2 | 2016 | 1592 | 0.040 |
Why?
|
| Reference Values | 1 | 2002 | 328 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2016 | 757 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2017 | 2639 | 0.040 |
Why?
|
| Acute Disease | 1 | 2002 | 663 | 0.040 |
Why?
|
| Radiography | 1 | 2002 | 558 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2007 | 1662 | 0.040 |
Why?
|
| Histamine H2 Antagonists | 1 | 2019 | 17 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 992 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2019 | 72 | 0.040 |
Why?
|
| Proton Pump Inhibitors | 1 | 2019 | 47 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2002 | 744 | 0.040 |
Why?
|
| Hematoma | 1 | 2018 | 85 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2016 | 5818 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 213 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 691 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 498 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 413 | 0.030 |
Why?
|
| Patient Transfer | 1 | 2016 | 93 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 808 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2016 | 216 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2016 | 165 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1225 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 931 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 2730 | 0.020 |
Why?
|
| Hospitalization | 1 | 2021 | 1403 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 374 | 0.020 |
Why?
|
| Logistic Models | 1 | 2016 | 1273 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 420 | 0.020 |
Why?
|
| Sex Factors | 1 | 2015 | 995 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1144 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 1715 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 746 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 703 | 0.020 |
Why?
|
| Animals | 1 | 2007 | 21450 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 2496 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2008 | 606 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 414 | 0.020 |
Why?
|
| Phenotype | 1 | 2009 | 1235 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 735 | 0.010 |
Why?
|
| Pulsatile Flow | 1 | 2003 | 10 | 0.010 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2003 | 25 | 0.010 |
Why?
|
| Vasomotor System | 1 | 2003 | 23 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2003 | 130 | 0.010 |
Why?
|
| Contrast Media | 1 | 2004 | 432 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2003 | 199 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2003 | 252 | 0.010 |
Why?
|
| Mutation | 1 | 2009 | 2670 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 6349 | 0.010 |
Why?
|